Literature DB >> 18258847

Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension.

Kewal Asosingh1, Micheala A Aldred, Amit Vasanji, Judith Drazba, Jacqueline Sharp, Carol Farver, Suzy A A Comhair, Weiling Xu, Lauren Licina, Lan Huang, Bela Anand-Apte, Mervin C Yoder, Rubin M Tuder, Serpil C Erzurum.   

Abstract

Vascular remodeling in idiopathic pulmonary arterial hypertension (IPAH) involves hyperproliferative and apoptosis-resistant pulmonary artery endothelial cells. In this study, we evaluated the relative contribution of bone marrow-derived proangiogenic precursors and tissue-resident endothelial progenitors to vascular remodeling in IPAH. Levels of circulating CD34+ CD133+ bone marrow-derived proangiogenic precursors were higher in peripheral blood from IPAH patients than in healthy controls and correlated with pulmonary artery pressure, whereas levels of resident endothelial progenitors in IPAH pulmonary arteries were comparable to those of healthy controls. Colony-forming units of endothelial-like cells (CFU-ECs) derived from CD34+ CD133+ bone marrow precursors of IPAH patients secreted high levels of matrix metalloproteinase-2, had greater affinity for angiogenic tubes, and spontaneously formed disorganized cell clusters that increased in size in the presence of transforming growth factor-beta or bone morphogenetic protein-2. Subcutaneous injection of NOD SCID mice with IPAH CFU-ECs within Matrigel plugs, but not with control CFU-ECs, produced cell clusters in the Matrigel and proliferative lesions in surrounding murine tissues. Thus, mobilization of high levels of proliferative bone marrow-derived proangiogenic precursors is a characteristic of IPAH and may participate in the pulmonary vascular remodeling process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18258847      PMCID: PMC2258264          DOI: 10.2353/ajpath.2008.070705

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  64 in total

1.  X chromosome-inactivation patterns of 1,005 phenotypically unaffected females.

Authors:  James M Amos-Landgraf; Amy Cottle; Robert M Plenge; Mike Friez; Charles E Schwartz; John Longshore; Huntington F Willard
Journal:  Am J Hum Genet       Date:  2006-07-27       Impact factor: 11.025

2.  Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.

Authors:  Rebecca M Shepherd; Benjamin J Capoccia; Steven M Devine; John Dipersio; Kathryn M Trinkaus; David Ingram; Daniel C Link
Journal:  Blood       Date:  2006-08-15       Impact factor: 22.113

3.  High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension.

Authors:  Joy D Cogan; Michael W Pauciulo; Amy P Batchman; Melissa A Prince; Ivan M Robbins; Lora K Hedges; Krista C Stanton; Lisa A Wheeler; John A Phillips; James E Loyd; William C Nichols
Journal:  Am J Respir Crit Care Med       Date:  2006-05-25       Impact factor: 21.405

4.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells.

Authors:  U M Gehling; S Ergün; U Schumacher; C Wagener; K Pantel; M Otte; G Schuch; P Schafhausen; T Mende; N Kilic; K Kluge; B Schäfer; D K Hossfeld; W Fiedler
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

5.  The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease.

Authors:  Hasan Güven; Rebecca M Shepherd; Richard G Bach; Benjamin J Capoccia; Daniel C Link
Journal:  J Am Coll Cardiol       Date:  2006-09-26       Impact factor: 24.094

6.  Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture.

Authors:  Shi Ju Zhang; Hao Zhang; Ying Jie Wei; Wen Jun Su; Zhong Kai Liao; Mai Hou; Jian Ye Zhou; Sheng Shou Hu
Journal:  Cell Res       Date:  2006-06       Impact factor: 25.617

7.  Circulating haemopoietic and endothelial progenitor cells are decreased in COPD.

Authors:  P Palange; U Testa; A Huertas; L Calabrò; R Antonucci; E Petrucci; E Pelosi; L Pasquini; A Satta; G Morici; M A Vignola; M R Bonsignore
Journal:  Eur Respir J       Date:  2006-03       Impact factor: 16.671

Review 8.  Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms.

Authors:  Kurt R Stenmark; Karen A Fagan; Maria G Frid
Journal:  Circ Res       Date:  2006-09-29       Impact factor: 17.367

9.  Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies.

Authors:  Jin Hur; Han-Mo Yang; Chang-Hwan Yoon; Choon-Soo Lee; Kyung-Woo Park; Ji-Hyun Kim; Tae-Youn Kim; Ju-Young Kim; Hyun-Jae Kang; In-Ho Chae; Byung-Hee Oh; Young-Bae Park; Hyo-Soo Kim
Journal:  Circulation       Date:  2007-10-01       Impact factor: 29.690

10.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.

Authors:  C Kalka; H Masuda; T Takahashi; W M Kalka-Moll; M Silver; M Kearney; T Li; J M Isner; T Asahara
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  77 in total

1.  Identification of a restriction point at the M/G1 transition in CHO cells.

Authors:  E Hullemann; J J M Bijvelt; A J Verkleij; C T Verrips; J Boonstra
Journal:  Cell Mol Life Sci       Date:  2004-03       Impact factor: 9.261

2.  Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension.

Authors:  Rubin M Tuder; Laura A Davis; Brian B Graham
Journal:  Am J Respir Crit Care Med       Date:  2011-11-10       Impact factor: 21.405

Review 3.  Regeneration of the vascular compartment.

Authors:  M U Becher; G Nickenig; N Werner
Journal:  Herz       Date:  2010-08       Impact factor: 1.443

Review 4.  Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies.

Authors:  Stephen L Archer; E Kenneth Weir; Martin R Wilkins
Journal:  Circulation       Date:  2010-05-11       Impact factor: 29.690

5.  Neovascular capacity of endothelial progenitor cells in the adult pulmonary circulation.

Authors:  Susan Majka; Diego F Alvarez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-04-03       Impact factor: 5.464

6.  High levels of zinc-protoporphyrin identify iron metabolic abnormalities in pulmonary arterial hypertension.

Authors:  Ilka Decker; Sudakshina Ghosh; Suzy A Comhair; Samar Farha; Wai Hong Wilson Tang; Margaret Park; Sihe Wang; Alan E Lichtin; Serpil C Erzurum
Journal:  Clin Transl Sci       Date:  2011-08       Impact factor: 4.689

7.  Bone Marrow-Derived Proangiogenic Cells Mediate Pulmonary Arteriole Stiffening via Serotonin 2B Receptor Dependent Mechanism.

Authors:  Nathaniel C Bloodworth; Cynthia R Clark; James D West; J Caleb Snider; Christa Gaskill; Sheila Shay; Christine Scott; Julie Bastarache; Santhi Gladson; Christy Moore; Reid D'Amico; Evan L Brittain; Harikrishna Tanjore; Timothy S Blackwell; Susan M Majka; W David Merryman
Journal:  Circ Res       Date:  2018-12-07       Impact factor: 17.367

8.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

9.  Increased Mutagen Sensitivity and DNA Damage in Pulmonary Arterial Hypertension.

Authors:  Chiara Federici; Kylie M Drake; Christina M Rigelsky; Lauren N McNelly; Sirena L Meade; Suzy A A Comhair; Serpil C Erzurum; Micheala A Aldred
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

10.  CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients.

Authors:  L Vroling; J S W Lind; R R de Haas; H M W Verheul; V W M van Hinsbergh; H J Broxterman; E F Smit
Journal:  Br J Cancer       Date:  2009-12-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.